ArticleDiabetes2021

Toll-Like Receptor 2 (TLR2) Knockout Abrogates Diabetic and Obese Phenotypes While Restoring Endothelial Function via Inhibition of NOX1.

Zhen Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.